688393 安必平
已收盘 05-15 15:00:01
资讯
新帖
简况
股市必读:5月8日安必平发布公告,股东减持43.11万股
证券之星 · 05-11
股市必读:5月8日安必平发布公告,股东减持43.11万股
每周股票复盘:安必平(688393)股东减持43.11万股占总股本0.46%
证券之星 · 05-10
每周股票复盘:安必平(688393)股东减持43.11万股占总股本0.46%
安必平(688393)披露股东减持股份结果公告,5月8日股价上涨1.36%
证券之星 · 05-08
安必平(688393)披露股东减持股份结果公告,5月8日股价上涨1.36%
股市必读:安必平年报 - 第四季度单季净利润同比下降334.76%
证券之星 · 04-30
股市必读:安必平年报 - 第四季度单季净利润同比下降334.76%
安必平(688393)3月31日股东户数0.83万户,较上期增加0.02%
证券之星 · 04-29
安必平(688393)3月31日股东户数0.83万户,较上期增加0.02%
图解安必平年报:第四季度单季净利润同比下降334.76%
证券之星 · 04-29
图解安必平年报:第四季度单季净利润同比下降334.76%
每周股票复盘:安必平(688393)变更会计政策及审计团队
证券之星 · 04-05
每周股票复盘:安必平(688393)变更会计政策及审计团队
安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%
证券之星 · 04-02
安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%
安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证
证券之星 · 03-30
安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证
每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元
证券之星 · 03-29
每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元
安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%
证券之星 · 03-26
安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%
方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录
美股速递 · 03-26
方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录
每周股票复盘:安必平(688393)2025年净亏4497万
证券之星 · 03-01
每周股票复盘:安必平(688393)2025年净亏4497万
安必平发布2025年度业绩快报,亏损0.45亿元
证券之星 · 02-27
安必平发布2025年度业绩快报,亏损0.45亿元
股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元
证券之星 · 02-02
股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元
每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元
证券之星 · 02-01
每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元
安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元
证券之星 · 01-30
安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元
安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元
智通财经 · 01-30
安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元
每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份
证券之星 · 01-25
每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份
安必平(688393.SH)股东南京干靖拟减持不超1.61%股份
智通财经 · 01-18
安必平(688393.SH)股东南京干靖拟减持不超1.61%股份
加载更多
公司概况
公司名称:
广州安必平医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-20
主营业务:
广州安必平医药科技股份有限公司的主营业务是自主品牌体外诊断试剂和诊断仪器的研发、生产和销售,以及其他品牌体外诊断产品、医疗仪器的经销。公司的主要产品是体外诊断试剂及相关配套设备。报告期内,公司各技术平台共新获57张国内医疗器械注册及备案证,20个产品获得CE证书。截至报告期末,公司共拥有三类医疗器械注册证17项,二类医疗器械注册证9项,一类医疗器械备案证623项;共拥有发明专利41项,实用新型专利88项,外观设计专利38项,软件著作权89项。
发行价格:
30.56
{"stockData":{"symbol":"688393","market":"SH","secType":"STK","nameCN":"安必平","latestPrice":24.4,"timestamp":1778828401000,"preClose":24.38,"halted":0,"volume":1771531,"delay":0,"changeRate":0.0008,"floatShares":93567700,"shares":93567700,"eps":-0.404,"marketStatus":"已收盘","change":0.02,"latestTime":"05-15 15:00:01","open":24.22,"high":25.36,"low":24.2,"amount":43952100,"amplitude":0.0476,"askPrice":24.4,"askSize":238,"bidPrice":24.37,"bidSize":31,"shortable":0,"etf":0,"ttmEps":-0.404,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":24.38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":26.82,"lowLimit":21.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":93567699,"isCdr":false,"pbRate":1.93,"roa":"--","roe":"--","epsLYR":-0.5,"committee":-0.723785,"marketValue":2283000000,"turnoverRate":0.0189,"status":0,"afterMarket":{"amount":0,"volume":0,"close":24.4,"buyVolume":0,"sellVolume":0,"time":1778830437559,"indexStatus":"已收盘 05-15 15:30:00","preClose":24.38},"floatMarketCap":2283000000},"requestUrl":"/m/hq/s/688393","defaultTab":"news","newsList":[{"id":"2634294484","title":"股市必读:5月8日安必平发布公告,股东减持43.11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634294484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634294484?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:23","pubTimestamp":1778444590,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,安必平报收于25.29元,上涨1.36%,换手率1.46%,成交量1.37万手,成交额3458.67万元。股本股东变化股东增减持5月8日安必平发布公告《安必平:股东减持股份结果公告》,其股东南京干靖创业投资合伙企业于2026年4月29日至2026年5月8日间合计减持43.11万股,占公司目前总股本的0.4607%,变动期间该股股价上涨8.08%,截止5月8日收盘报25.29元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100002002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634295412","title":"每周股票复盘:安必平(688393)股东减持43.11万股占总股本0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634295412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634295412?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:48","pubTimestamp":1778356093,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,安必平报收于25.29元,较上周的24.6元上涨2.8%。股东减持股份结果公告南京干靖创业投资合伙企业作为持有广州安必平医药科技股份有限公司5%以下的股东,在本次减持计划实施前持有公司1,502,343股,占总股本的1.61%。截至减持计划届满,南京干靖仍持有公司1,071,284股,占总股本的1.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633643785","title":"安必平(688393)披露股东减持股份结果公告,5月8日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633643785","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633643785?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:24","pubTimestamp":1778235859,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,安必平报收于25.29元,较前一交易日上涨1.36%,最新总市值为23.66亿元。近日,公司披露《股东减持股份结果公告》。自2026年1月19日披露减持计划后,南京干靖于2026年4月29日至5月8日期间,通过集中竞价交易方式减持公司股份431,059股,占总股本的0.46%,减持价格区间为24.38至25.40元/股,合计减持金额为10,660,034.39元。截至减持计划届满,南京干靖仍持有公司1,071,284股,占总股本的1.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800035833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631512573","title":"股市必读:安必平年报 - 第四季度单季净利润同比下降334.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631512573","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631512573?lang=zh_cn&edition=full","pubTime":"2026-04-30 07:18","pubTimestamp":1777504697,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,安必平报收于24.35元,上涨4.06%,换手率2.41%,成交量2.26万手,成交额5501.68万元。当日关注点来自:安必平2025年归母净利润亏损4702.34万元,同比下滑320.86%,连续第四季度录得单季亏损。股本股东变化股东户数变动近日安必平披露,截至2026年3月31日公司股东户数为8268.0户,较12月31日增加2.0户,增幅为0.02%。如总股本发生变动,将维持每股分配比例不变,相应调整总金额。该方案尚需提交公司2025年年度股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000025069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596341","title":"安必平(688393)3月31日股东户数0.83万户,较上期增加0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596341?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:43","pubTimestamp":1777455828,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安必平披露,截至2026年3月31日公司股东户数为8268.0户,较12月31日增加2.0户,增幅为0.02%。在医疗器械行业个股中,安必平股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年12月31日至2026年3月31日,安必平区间跌幅为0.68%,在此期间股东户数增加2.0户,增幅为0.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631587903","title":"图解安必平年报:第四季度单季净利润同比下降334.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631587903","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631587903?lang=zh_cn&edition=full","pubTime":"2026-04-29 02:10","pubTimestamp":1777399854,"startTime":"0","endTime":"0","summary":"证券之星消息,安必平2025年年报显示,当年度公司主营收入3.44亿元,同比下降26.84%;归母净利润-4702.34万元,同比下降320.86%;扣非净利润-6388.89万元,同比下降548.22%;其中2025年第四季度,公司单季度主营收入9152.55万元,同比下降22.51%;单季度归母净利润-3625.63万元,同比下降334.76%;单季度扣非净利润-4694.39万元,同比下降452.89%;负债率9.94%,投资收益1749.75万元,财务费用-412.28万元,毛利率63.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900006085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625118036","title":"每周股票复盘:安必平(688393)变更会计政策及审计团队","url":"https://stock-news.laohu8.com/highlight/detail?id=2625118036","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625118036?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:51","pubTimestamp":1775332268,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,安必平报收于22.75元,较上周的23.57元下跌3.48%。本周,安必平3月31日盘中最高价报25.23元。关于变更项目合伙人及签字会计师的公告广州安必平医药科技股份有限公司于2026年4月2日发布公告,因原项目合伙人、签字注册会计师熊树蓉离职,中汇会计师事务所指派肖强光接替其担任公司2025年度财务报表及内部控制审计的项目合伙人及签字注册会计师。本次变更不会对公司审计工作产生不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624740500","title":"安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624740500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624740500?lang=zh_cn&edition=full","pubTime":"2026-04-02 23:08","pubTimestamp":1775142495,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,安必平报收于23.89元,较前一交易日下跌3.28%,最新总市值为22.35亿元。近日,广州安必平医药科技股份有限公司发布公告称,因原项目合伙人、签字注册会计师熊树蓉离职,中汇会计师事务所指派肖强光接替其担任公司2025年度财务报表及内部控制审计的项目合伙人及签字注册会计师。肖强光具备专业胜任能力,符合独立性要求,近三年签署及复核4家上市公司审计报告,曾于2025年10月24日因执业问题被深交所采取书面警示措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200043234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623631586","title":"安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623631586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623631586?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:40","pubTimestamp":1774863647,"startTime":"0","endTime":"0","summary":"安必平公告称,公司近日收到国家药监局颁发的《医疗器械注册证》,产品为宫颈细胞数字病理图像辅助诊断软件,属于Ⅲ类医疗器械,有效期至2031年3月。该软件作为辅助诊断工具,可对宫颈细胞数字病理图像进行全片分析、自动识别并标记疑似病变细胞,供执业病理医师参考,但不能作为临床诊断决策的唯一依据,不适用于宫颈癌筛查。产品未来实际销售情况取决于市场推广效果及市场需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1574","BK1100","BK1222","BK0239","09996","688393","159883","09997"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623330703","title":"每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623330703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623330703?lang=zh_cn&edition=full","pubTime":"2026-03-29 05:05","pubTimestamp":1774731918,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:安必平预计2026年度日常关联交易额度为1,996.65万元。关于预计2026年度日常关联交易额度的公告广州安必平医药科技股份有限公司预计2026年度日常关联交易额度合计为1,996.65万元,涉及向关联方购买原材料、销售产品、提供劳务及租赁资产等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622869401","title":"安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622869401?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:39","pubTimestamp":1774535955,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘,安必平报收于22.69元,较前一交易日下跌3.41%,最新总市值为21.23亿元。该股当日开盘23.48元,最高23.59元,最低22.54元,成交额达2811.77万元,换手率为1.31%。公告显示,公司预计2026年度日常关联交易额度合计为1,996.65万元,涉及向关联方购买原材料、销售产品、提供劳务及租赁资产等。关联交易遵循公允、合理原则,定价参考市场价格协商确定,不存在损害公司及股东利益的情形。公司与各关联方保持独立性,不会对关联方形成较大依赖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173700785","title":"方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=1173700785","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173700785?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:45","pubTimestamp":1774529113,"startTime":"0","endTime":"0","summary":"在实现创纪录的年度增长和盈利能力后,方舟健客宣布任命医疗行业资深人士王海蛟为公司首席执行官。此项人事任命标志着公司在强劲业绩基础上,进一步强化核心管理团队的战略举措。\n王海蛟在医疗健康领域拥有深厚的行业经验和卓越的领导履历,他的加入有望为方舟健客下一阶段的业务拓展和战略深化注入新的动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086","BK1247","BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616647845","title":"每周股票复盘:安必平(688393)2025年净亏4497万","url":"https://stock-news.laohu8.com/highlight/detail?id=2616647845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616647845?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:48","pubTimestamp":1772304491,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,安必平报收于27.58元,较上周的27.67元下跌0.33%。本周,安必平2月24日盘中最高价报28.01元。本周关注点业绩披露要点:安必平2025年归属净利润亏损4,497.17万元,同比减少311.22%。公司公告汇总广州安必平医药科技股份有限公司发布2025年度业绩快报,营业总收入34,726.91万元,同比下降26.24%;营业利润-5,191.28万元,同比下降571.86%;归属于母公司所有者的净利润-4,497.17万元,同比下降311.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614880207","title":"安必平发布2025年度业绩快报,亏损0.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614880207","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614880207?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181057,"startTime":"0","endTime":"0","summary":"证券之星消息,安必平近日即将发布2025年年报,根据2月27日发布的业绩快报,归属净利润亏损0.45亿元,同比减少311.22%。报告期末,公司总资产 129,086.81 万元,较报告期初减少 5.27%;归属于母公司的所有者权益 119,003.73 万元,较报告期初减少 5.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700026508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608889572","title":"股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608889572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608889572?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:21","pubTimestamp":1769973670,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,安必平报收于27.84元,下跌0.82%,换手率3.19%,成交量2.98万手,成交额8267.45万元。来自:安必平2025年业绩预亏主因HPV产品线售价下降导致收入减少约4,650万元,毛利减少约4,600万元,并叠加研发投入增加及资产减值影响。安必平发布业绩预告,预计2025年全年扣非后净利润亏损6200万元至7200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608431077","title":"每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608431077","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608431077?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:04","pubTimestamp":1769886253,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,安必平报收于27.84元,较上周的30.17元下跌7.72%。本周,安必平1月26日盘中最高价报30.65元。安必平当前最新总市值26.05亿元,在医疗器械板块市值排名120/127,在两市A股市值排名4892/5184。安必平发布业绩预告,预计2025年全年归属净利润亏损4200万元至5200万元。业绩下滑主要因HPV产品线售价下降导致收入减少约4,650万元,毛利减少约4,600万元,以及研发投入增加和资产减值计提所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607738090","title":"安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607738090","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607738090?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:44","pubTimestamp":1769762674,"startTime":"0","endTime":"0","summary":"证券之星消息,安必平发布业绩预告,预计2025年全年扣非后净利润亏损6200万元至7200万元。安必平2025年三季报显示,前三季度公司主营收入2.53亿元,同比下降28.29%;归母净利润-1076.71万元,同比下降136.34%;扣非净利润-1694.49万元,同比下降174.5%;其中2025年第三季度,公司单季度主营收入9352.3万元,同比下降24.95%;单季度归母净利润173.14万元,同比下降86.95%;单季度扣非净利润-223.26万元,同比下降118.27%;负债率8.64%,投资收益85.61万元,财务费用-361.35万元,毛利率64.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607922990","title":"安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607922990","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607922990?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:59","pubTimestamp":1769759989,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)发布公告,公司预计2025年年度实现归属于母公司所有者的净利润-5200万元到-4200万元,与上年同期(法定披露数据)相比,将出现亏损,减少7,329.13万元到6,329.13万元,同比减少344.23%到297.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606320502","title":"每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606320502","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606320502?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:14","pubTimestamp":1769282052,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,安必平报收于30.17元,较上周的30.49元下跌1.05%。本周关注点公司公告汇总:南京干靖拟减持安必平不超过1.61%股份,减持方式包括集中竞价和大宗交易。公司公告汇总股东减持股份计划公告截至公告披露日,南京干靖持有广州安必平医药科技股份有限公司1,502,343股,占总股本的1.61%,股份来源于IPO前取得。其中集中竞价减持不超过935,676股,大宗交易减持不超过566,667股,减持期间为2026年2月9日至2026年5月8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604357920","title":"安必平(688393.SH)股东南京干靖拟减持不超1.61%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2604357920","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604357920?lang=zh_cn&edition=full","pubTime":"2026-01-18 16:13","pubTimestamp":1768724027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)公告,公司股东南京干靖拟通过集中竞价方式及大宗交易方式减持所持有的公司股份不超过150.23万股(含本数),不超过公司目前总股本的1.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779055203659,"stockEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0379},{"period":"3month","weight":-0.1182},{"period":"6month","weight":-0.0758},{"period":"1year","weight":-0.2056},{"period":"ytd","weight":0.03}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州安必平医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8268人(较上一季度增加0.02%)","perCapita":"11316股","listingDate":"2020-08-20","address":"广东省广州市黄埔区科学城风信路科信街2号","registeredCapital":"9356万元","survey":" 广州安必平医药科技股份有限公司的主营业务是自主品牌体外诊断试剂和诊断仪器的研发、生产和销售,以及其他品牌体外诊断产品、医疗仪器的经销。公司的主要产品是体外诊断试剂及相关配套设备。报告期内,公司各技术平台共新获57张国内医疗器械注册及备案证,20个产品获得CE证书。截至报告期末,公司共拥有三类医疗器械注册证17项,二类医疗器械注册证9项,一类医疗器械备案证623项;共拥有发明专利41项,实用新型专利88项,外观设计专利38项,软件著作权89项。","listedPrice":30.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安必平,688393,安必平股票,安必平股票老虎,安必平股票老虎国际,安必平行情,安必平股票行情,安必平股价,安必平股市,安必平股票价格,安必平股票交易,安必平股票购买,安必平股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}